GSK takes billion-dollar drug fight with Gilead to top AIDS meeting
June 20, 2018 at 08:34 AM EDT
LONDON, June 20 (Reuters) - GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.